Welcome to our dedicated page for FNQ news (Ticker: FNQ), a resource for investors and traders seeking the latest updates and insights on FNQ stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FNQ's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FNQ's position in the market.
On August 4, 2022, Fineqia International Inc. (CSE: FNQ, OTC: FNQQF) announced an increase in its non-brokered private placement from 400 million units to 500 million units at C$0.01 each, aiming to raise up to C$5 million. Following this, the company completed the first tranche, issuing 34.5 million units to raise C$345,000. Each unit consists of one common share and one warrant, exercisable at C$0.05 for three years. Proceeds will enhance working capital and reduce debt. The offering remains subject to regulatory approval.
